SHARONBIO — Sharon Bio-Medicine Income Statement

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual income statement for Sharon Bio-Medicine, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2015 June 30th	2016 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	9 M	12 M	12 M	12 M
Source:	ARS	ARS	PRESS	PRESS	PRESS
Standards:	IAS	IAS	—	—	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,385	2,535	1,729	1,884	1,950
Cost of Revenue
Gross Profit	60.2	-929	866	932	996
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	9,767	4,747	1,627	1,734	1,804
Operating Profit	-1,382	-2,213	101	150	146
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2,292	-2,903	140	177	190
Provision for Income Taxes
Net Income After Taxes	-2,339	-3,003	140	177	190
Net Income Before Extraordinary Items
Net Income	-2,339	-3,003	140	177	190
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-2,339	-3,003	140	177	190
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-15	-21.3	24.4	30.7	33
Dividends per Share